Skip to main content
. 2020 Nov 6;21(21):8324. doi: 10.3390/ijms21218324
ACT Adoptive T cell therapy
APC Antigen presenting cells
APL Altered peptide ligand
HLA Human leucocyte antigen
CDR Complementary-determining region
NSPM Nonsynonymous point mutations
MHC Major histocompatibility complex
MS
PBMCs
Mass spectrometry
peripheral blood mononuclear cells
pMHC Peptide-major histocompatibility complex
TAA Tumor-associated antigen
TCR T cell receptor
TILs Tumor infiltrating lymphocytes
WES Whole exome sequencing